MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 58 filers reported holding MONTE ROSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,011,194 | -28.0% | 837,410 | +2.9% | 0.00% | 0.0% |
Q2 2023 | $5,574,283 | -12.0% | 813,764 | +0.1% | 0.00% | 0.0% |
Q1 2023 | $6,332,499 | -16.3% | 812,901 | -18.2% | 0.00% | -50.0% |
Q4 2022 | $7,565,824 | -2.8% | 994,195 | +4.3% | 0.00% | 0.0% |
Q3 2022 | $7,785,000 | +571.7% | 952,956 | +695.2% | 0.00% | – |
Q2 2022 | $1,159,000 | +75.1% | 119,832 | +153.9% | 0.00% | – |
Q1 2022 | $662,000 | -34.2% | 47,190 | -4.2% | 0.00% | – |
Q4 2021 | $1,006,000 | +20.3% | 49,281 | +31.2% | 0.00% | – |
Q3 2021 | $836,000 | -61.5% | 37,549 | -60.8% | 0.00% | – |
Q2 2021 | $2,174,000 | – | 95,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |